Free Trading + Demat Account

IPO Discussion Page

Please Note: All views and opinions expressed in reader comments are solely those of the individual submitting the comment, and not those of the or its staff.

bangalore king's Comments

Close bangalore king's Comments


12. bangalore king  Feb 14, 2017 11:54:40 PM IST Reply


Till NSE actually comes to the markets, would it make sense at all to stick by with BSE because they are not going to degrow from here. There is this marginal chance that business may actually be up from here?

One reason to buy this IPO would be for a dividend yield. I believe they will be selling a substantial portion of their holding in CDSL maybe later this year that will give a huge cash amount to the BSE and I expect them to be transferring that cash because they do not need the cash for operations. They are a cash rich company. Most of their profits comes from the interests they earn from their cash deposits.

If that is the case, that will be one big result thing to look forward to this year. So there will be a dividend yield, I expect reasonable amount of money per share to be distributed. Having said that, from a longer term perspective is it an exchange that you want to own? You have two exchanges today -- MCX and BSE that are listed and on both the volumes growth in terms of volumes trade has not been substantial. I say this for NSE as well. The bet could be that in the next 10 years this will double, triple, quadruple but since I have not seen that volume really coming into that market. I do not know if BSE is a great play and so I will wait for this.
11. bangalore king  Feb 7, 2017 8:31:15 AM IST Reply

BSE Limited IPO

Results/Dividend 14-Feb-2017

to inter alia consider and approve, the standalone and consolidated unaudited financial results of the Company under Ind AS for the quarter / nine months ended December 31, 2016, and to consider declaration of interim dividend, if any, to the equity shareholders of the Company.
11.1. Kiran Gohel  Feb 7, 2017 9:30:37 AM IST

BSE Limited IPO

please provide a link
10. bangalore king  Jan 21, 2017 11:29:18 AM IST Reply

BSE Limited IPO

Mumbai, January 20:

SEBI is working towards reducing the number of days taken for listing of a company’s shares from the date of closure of its public offering — to four working days (called T+ 4) from six now.

The T+6 timeline was implemented effective January 1, 2016. Prior to this, the time taken was T +12 (effective May 3, 2010) and before that T+22.

Speaking at the International Conference on Certification & Capacity Building in Financial Markets at the NISM Campus at Patalganga in Navi Mumbai, UK Sinha, Chairman, SEBI, said: “The SEBI team is already working to bring the timeline down to T+4 days.”
10.1. ShareView  Jan 21, 2017 6:21:25 PM IST

BSE Limited IPO

it''s going to be implemented by April.

Do you know anything about new sebi rules regarding allotment ?
9. bangalore king  Jan 21, 2017 11:23:10 AM IST Reply

BSE Limited IPO

Avenue Supermarts Ltd, which runs the D-Mart store chain, and security services firm Security and Intelligence Services (India) Ltd (SIS), plan to go public next month, three people aware of the development said.

While Avenue Supermarts is planning to raise around Rs1,870 crore through its IPO, CX Partners-backed SIS is expected to raise around Rs1,000 crore, as per the draft red herring prospectus (DRHP) filed by the two companies and an earlier Mint report.

“They are targeting their launch in the second half of the month of February. The idea is that with the Union budget happening at the start of February, the markets will have stabilized by the end of the month and so that will be a good time to launch the deals,” one of the three people cited above said, requesting anonymity.
8. bangalore king  Jan 5, 2017 12:25:38 PM IST Reply

BSE Limited IPO


Maintain overweight, raise target to `385 from `365

See lower rates and pickup in financial savings since demonetization

Co has likely steady persistency trends helped by zero cash collections

Short-term growth moderation possible in credit life premiums following lower home loan sales

Co has balanced distribution mix, rising protection mix, improving persistency/costs

See multiyear improvement in profitability leading to strong VNB CAGR during F16-F19
7. bangalore king  Dec 19, 2016 6:17:42 PM IST Reply

Laurus Labs Ltd IPO

NOMURA INDIA INVESTMENT FUND MOTHER FUND bought 7,35,000 shares at 477.5 ..
6. bangalore king  Dec 5, 2016 8:42:11 PM IST Reply

Laurus Labs Ltd IPO

Anchor list
5. bangalore king  Dec 3, 2016 7:11:47 PM IST Reply

Laurus Labs Ltd IPO

I see lot of boarders are giving crazy target on this IPO listing.. The fundamentals are strong but market is uncertain and valuation are higher. So it may not get listed with high premiums.

Shares will be deposited in demat on December 15 and listing may take place on December 16 around Rs450/460 and may cross Rs475 in favorable
condition. It may give five-seven per cent gain on listing.

The investors can subscribe the issue with 2-3 year outlook.
4. bangalore king  Dec 1, 2016 10:54:34 PM IST Reply

Laurus Labs Ltd IPO

For FY 2016, Laurus Labs had basic earnings per share (EPS) of INR20.86 while diluted EPS stood at INR13.48 on a consolidated basis. The price band of INR426 – 428 per share values the company at a PE ratio of 31.6 – 31.75. These are rich valuations considering sub-30 figures for listed peers like Aurobindo Pharma and Divis Laboratories.
4.1. ShareView  Dec 2, 2016 11:02:52 AM IST

Laurus Labs Ltd IPO

Dear Experts ,
w.r.t P/E , This point is remarkable.
Divis Lab is trading @ 29 p/e &
Auropharma trading @ 22 p/e
Co. specified in the ''basis of issue price''

No doubt Issue is good for listing gain
But does it justify for long term ?

We would be grateful for your reply
3. bangalore king  Nov 28, 2016 8:18:11 PM IST Reply

Sheela Foam Ltd IPO

Anchor allocation -
2. bangalore king  Nov 26, 2016 11:25:12 PM IST Reply

Sheela Foam Ltd IPO

original share price for the main promoter Sheela Gautam
is just 3 paisa per share, for Rahul Gautam it is 12 paisa and for selling shareholders
it is just 33 paisa per share, while offer price is Rs730.
- Before filling DRHP, the promoters have issued bonus shares in ratio of 2:1.
- In the resolution passed on May 31, 2016, the face value of the share has been
brought down to Rs 5 from Rs10. If they had not done so the IPO offer price could
have been Rs1460, so they have tried to misguide the investors even before filling
- Before entering into the market the net profit has surged 146% in FY2016. While
the income growth has come down from 11.23 in FY2015 to 9.20% in FY2016. So
it creates doubts about authenticity of the figures.
- Raw material accounts for 50-60% in the company''s income. It used to get benefit
of rockbottom prices in last few years. So the current margins are low but difficult
to maintain.
- The sales is under pressure due to demonetization. After Poor Listing of Varun
Beverages and Flop show of Green Signal Bio Pharma, will the investors ready to
take risk?
- The experts in the market expect the IPO to get listed at discount and also indicated
that deal is done with QIB and HNI investors so they are list bothered about
retail investors. So the main question is that Is the issue worth subscribing?
2.1. dpcdsl  Nov 26, 2016 11:56:28 PM IST

Sheela Foam Ltd IPO

Good analysis.
2.2. jigaReligare  Nov 27, 2016 7:50:07 AM IST

Sheela Foam Ltd IPO

thanks for info
1. bangalore king  Nov 21, 2016 12:05:15 AM IST Reply

Sheela Foam Ltd IPO

Shareholders can subscribe to the rights issue of Karnataka Bank, the price for which has been fixed at ₹70 per share. Open until November 21, the issue of shares will be done in the ratio of 1:2 — one rights share for every two held by the shareholders.

Though the bank has seen sluggish growth in loans over the last two to three years and has also had to deal with rising bad loans, prospects over the long run appear sanguine.

The price of the rights issue is at a huge discount to the current market price of ₹121 (ex-rights). If the price holds up, there is scope for immediate gains. But that’s only the icing on the cake.

For long-term investors, the bank’s earnings trajectory and growth prospects should be the deciding factor for subscribing to the rights issue.

In this regard, the bank’s strong regional presence, conscious decision to cut back on corporate credit, increased focus on retail loans and stable margins augur well for its earnings outlook over the next two to three years. At 0.7 times the one-year forward book, the stock trades in line with its three-and five-year average.

Compared to other regional banks such as South Indian Bank (0.7 times) and Federal Bank (1.4 times), the stock is attractively priced. Pick-up in earnings on account of easing asset quality pressure and improving credit growth can see the stock re-rate over the next two to three years.
13.1. RAJA HINDUSTANI  Nov 22, 2016 7:15:04 PM IST

Sheela Foam Ltd IPO

But Why have they Extended ? Is it under subscribed ??
By Popular Stock Brokers
ProStocks, The Flat Rate Discount Stock Broker
Flat Fee Broker

Rs 899 Unlimited Equity
Rs 499 Unlimited Curr
or Rs 15 per Trade

Lowest Transaction Charge
Lowest Call & Trade Fee
Lowest Stamp Duty

FREE Trading + Demat Acct

Flat Rs 20 Per Trade
Free Equity Delivery Trades

Rs 100 off on account opening* + 100% brokerage refund if in 60 days you have made net profits

Enquire Now
(* on online account opening)

Intraday @ 0.02%
Delivery @ 0.15%

Rs 0 account opening fee
(Rs 400 waived)

Request Demo

RKSV Discount Broker  RKSV

Ditch & Switch

Switch to RKSV and earn brokerage credit of Rs 2000

Get RKSV Trading Account

Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading + Demat Acct
(Rs 1150 waived)

Request Call Back

More About Brokers

Special Offers Broker Reports

Message Board

Stock Message Board